Feb 1 (Reuters) - U.S. Food and Drug Administration Commissioner Scott Gottlieb:
* FDA COMMISSIONER SCOTT GOTTLIEB ISSUES STATEMENT ON ONGOING EFFORTS TO MITIGATE IMPACT OF SALINE SHORTAGES DURING FLU SEASON
* FDA’S GOTTLIEB SAYS “THIS YEAR’S FLU SEASON HAS BEEN PARTICULARLY CHALLENGING, WITH A NOTABLE NUMBER OF CASES LEADING TO HOSPITALIZATION”
* FDA’S GOTTLIEB SAYS “MANAGING THE THOUSANDS OF FLU-RELATED HOSPITALIZATIONS HAS INCREASED THE DEMAND FOR CERTAIN SALINE PRODUCTS”
* FDA’S GOTTLIEB - THIS YEAR’S WORSE-THAN-NORMAL FLU SEASON & WORKAROUNDS DEPLOYED BY HEALTH CARE PROVIDERS HAVE INCREASED DEMAND FOR SALINE, OTHER PRODUCTS Source text for Eikon: